Liver Diseases  >>  interferon omega (ITCA 638)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
interferon omega (ITCA 638) / Intarcia, Boehringer Ingelheim
NCT00097045: Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

Completed
2
90
RoW
omega interferon, Ribavirin
Intarcia Therapeutics
Hepatitis C
 
12/06

Download Options